Skip to main content

Predictors of depression in women with polycystic ovary syndrome


The aim of this study is to assess the prevalence and predictors of depressive symptoms in women with polycystic ovary syndrome (PCOS). In a cross-sectional study of 114 women seeking consultation for symptoms of PCOS (menstrual irregularity, hirsutism, and/or acne), personal and family history of depression (HD and FHD respectively) were enquired. Vitamin D status (n = 104) and manifest depressive symptoms assessed by personal health questionnaire (PHQ) (MD) were evaluated in a subset (85). Relationships between HD and MD with PCOS symptoms, FHD, and vitamin D status were assessed using adjusted analyses. Thirty-five percent acknowledged a HD; MD (PHQ > 4) was apparent in 43 %. HD was associated with hirsutism (OR 2.4, 95 % CI 1.01–5.9), disturbed sleep (OR 3.0, 95 % CI 1.3–6.9), and with FHD (OR 4.8, 95 % CI 1.7–13.5). Disturbed sleep (OR 2.4, 95 % CI 1.01–5.7) and FHD (OR 3.8, 95 % CI 1.3–11.2) were independent predictors of HD adjusting for race and BMI. An inverse correlation was noted between serum 25 OH vitamin D (25OHD) levels and PHQ score, but only in those with vitamin D deficiency (25OHD ≤ 30 ng/ml, n = 57, r =−0.32, p = 0.015). 25OHD < 20 ng/ml (OR 3.5, 95 % CI 1.1–11.8) and HD (OR 12.8, 95 % CI 3.6–45.2) predicted scoring in the highest PHQ tertile after adjusting for hirsutism, BMI, and race. In women with PCOS, disturbed nocturnal sleep and FDH predicted personal HD, whereas HD and vitamin D deficiency related to the severity of MD symptoms.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. Azziz R, Woods KS, Reyna R, Key TJ et al (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749

    CAS  PubMed  Article  Google Scholar 

  2. Catherine Marin DU, Woods KS, Alfred A, Bartolucci, Ricardo A (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345–1350

    Article  Google Scholar 

  3. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L (2005) A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 152(5):986–992

    CAS  PubMed  Article  Google Scholar 

  4. Dokras A (2012) Mood and anxiety disorders in women with PCOS. Steroids 77(4):338–341

    CAS  PubMed  Article  Google Scholar 

  5. Drosdzol A, Skrzypulec V, Plinta R (2010) Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 31(3):168–175

    PubMed  Article  Google Scholar 

  6. Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES (2011) Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 86(11):1050–1055

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930

    CAS  PubMed  Article  Google Scholar 

  8. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. Wiley, New York

    Book  Google Scholar 

  9. Jaussent I, Bouyer J, Ancelin ML, Akbaraly T, Pérès K, Ritchie K, Besset A, Dauvilliers Y (2011) Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep 34(8):1103–1110

    PubMed Central  PubMed  Google Scholar 

  10. Jaworska N, Thompson A, Shah D, Fisher D, Ilivitsky V, Knott V (2012) Acute tryptophan depletion effects on the vertex and late positive potentials to emotional faces in individuals with a family history of depression. Neuropsychobiology 65(1):28–40

    PubMed  Article  Google Scholar 

  11. Kao CC, Huang CJ, Wang MY, Tsai PS (2008) Insomnia: prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population. Qual Life Res 17(8):1073–1080

    PubMed  Article  Google Scholar 

  12. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92(3):1053–1058

    CAS  PubMed  Article  Google Scholar 

  13. Kroenke K, Spitzer RL, Williams JB, Löwe B (2010) The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 32(4):345–359, Review

    PubMed  Article  Google Scholar 

  14. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K et al (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270

    PubMed  Article  Google Scholar 

  15. Norman A (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. In: The American Journal of Clinical Nutrition, 491S–9S

  16. Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J et al (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28(12):965–968

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. Parish J (2009) Sleep-related problems in common medical conditions. Chest 135(2):563–572

    PubMed  Article  Google Scholar 

  18. Rashidi B, Haghollahi F, Shariat M, Zayerii F (2009) The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 48(2):142–147

    PubMed  Article  Google Scholar 

  19. Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84, Review

    PubMed  Article  Google Scholar 

  20. Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011) An update on the presence of psychiatric comorbidities in acne patients, Part 2: depression, anxiety, and suicide. Cutis 88(2):92–97

    PubMed  Google Scholar 

  21. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S (2010) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33(4):234–238

    CAS  PubMed  Article  Google Scholar 

  22. Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  23. Wehr E, Schweighofer N, Giuliani A, et al. (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. In: European Journal of Endocrinology, 575–582

Download references

Author information



Corresponding author

Correspondence to Lubna Pal.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Naqvi, S.H., Moore, A., Bevilacqua, K. et al. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health 18, 95–101 (2015).

Download citation


  • Polycystic ovary syndrome
  • Vitamin D
  • 25OHD
  • Depression
  • PHQ